“Nauka, Tekhnika, Meditsina” (NTM) LTd. is a private pharmaceutical company commited to research, development and commercialization of innovative pharmaceutical products (smal synthetic molecules) for the profilactis and treatment of influenza and tick -borne encephalitis, treatment of epilepcy and enchancing the cerebral circulation.
NTM is pursuing strategic partnership to :

- to build value by developing our product portfolio through continued nonclinical studies and clinical trials to the point where there is a potential for licensing opportunities with international biotechnology and pharmaceutical partners/collaborators;

- to get an equity investment from international venture capital funds, banks or other financial organizations;

- commercialisation/joint development/joint R&D/ joint venture, etc.